亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Regulation of the vaginal microbiome reduces rate of HIV infection

總結
This technology is a combination of vaccines, probiotics, and antibiotics that regulate the vaginal microbiome to reduce the infection rate of human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs).
技術優勢
Cost-effective prevention of HIV infectionAlso reduces risk of infection with other STIs
技術應用
Preventative vaccine to reduce HIV infection risk Antibiotics for prevention of HIV and STIsVaginal probiotics to maintain a healthy bacterial microbiome
詳細技術說明
None
*Abstract
None
*Inquiry
Ron KatzColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
*IR
CU17009
*Principal Investigation
*Publications
Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, Williamson C, Little F, Mansoor LE, Naranbhai V, Lauffenburger DA, Ronacher K, Walzl G, Garrett NJ, Williams BL, Couto-Rodriguez M, Hornig M, Lipkin WI, Grobler A, Abdool Karim Q, Abdool Karim SS. “Genital inflammation and the risk of HIV acquisition in women.” Clin Infect Dis. 2015 Jul 15;61(2):260-9.Tech Ventures Reference:IR CU17009Licensing Contact: Ron Katz
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備